- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Melanoma Brain Metastasis
Total 41709 results
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
University of ZurichCompleted
-
University of PittsburghBristol-Myers SquibbWithdrawn
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Hadassah Medical OrganizationCompletedMetastatic MelanomaIsrael
-
Ludwig Institute for Cancer ResearchAgonOxWithdrawn
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Sheba Medical CenterUnknownMetastatic MelanomaIsrael
-
Myrexis Inc.Completed
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
Ludwig-Maximilians - University of MunichUnknownMelanoma | Radiotherapy | Metastatic DiseaseGermany
-
California Cancer Assocaties for Research & ExcellenceUnknownMetastatic Melanoma | Malignant Melanoma of Skin Stage IIIUnited States
-
Vastra Gotaland RegionNot yet recruitingMetastatic Cutaneous Melanoma | Uveal Melanoma
-
Qilu Hospital of Shandong UniversityNot yet recruitingLocally Advanced or Metastatic Acral Malignant MelanomaChina
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Carman GiacomantonioNova Scotia Health AuthorityWithdrawnCutaneous Metastatic Melanoma
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
Wilson MillerActive, not recruitingMetastatic Malignant MelanomaCanada
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Northern California Melanoma CenterPfizer; Schering-PloughTerminated
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbCompletedPhase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for MelanomaRecurrent Melanoma | Stage IV Melanoma | Tumors Metastatic to BrainUnited States
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
Vastra Gotaland RegionRecruitingMelanoma | In-Transit MetastasisSweden, Netherlands
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
NYU Langone HealthCompletedMetastatic Malignant Melanoma
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
Jules Bordet InstituteWithdrawnMetastatic HER2-positive Breast Cancer With Brain Metastasis
-
Vastra Gotaland RegionWithdrawnMelanoma | Surgery | Metastatic Melanoma | Melanoma Stage IVSweden
-
Delcath Systems Inc.National Cancer Institute (NCI)CompletedMetastatic Cancer | Intraocular Melanoma | Melanoma (Skin)United States
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
DNA TherapeuticsCompleted
-
St. Louis UniversityCompletedMelanoma | Metastatic Melanoma | Stage IV Melanoma | Unresectable Malignant Neoplasm | Stage III MelanomaUnited States
-
BiocadActive, not recruitingUnresectable or Metastatic MelanomaRussian Federation
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Bristol-Myers SquibbCompletedAdvanced or Metastatic MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic (Stage IV) MelanomaFrance
-
Yale UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingMelanoma | Non-small Cell Lung Cancer | Brain MetastasisUnited States
-
Perspective TherapeuticsRecruitingMetastatic Melanoma | Melanoma (Skin) | Mucosal Melanoma | Melanoma Stage IV | Melanoma Stage III | Melanoma, UvealUnited States
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Philogen S.p.A.Active, not recruiting